Ensuring data’s reliability, integrity, and accuracy is paramount in scientific research and development. This is where Good Laboratory Practice (GLP) standards come into play, serving as a beacon of quality and reliability in laboratory environments. GLP standards are principles intended to promote the quality and validity of non-clinical laboratory studies, crucial for regulatory submissions and the safety assessment of chemicals and pharmaceuticals. In this blog, we’ll delve into what GLP standards are, their importance, and how they impact the research and development landscape.

What Are GLP Standards?

Good Laboratory Practice standards are rules and guidelines developed to ensure the uniformity, consistency, reproducibility, quality, and integrity of chemical non-clinical safety tests, including pharmaceuticals, pesticides, cosmetic substances, veterinary drugs, and food and feed additives. Initially developed in the 1970s in response to research integrity issues, GLP standards have been adopted internationally, guided by organizations such as the Organization for Economic Co-operation and Development (OECD).

 Key Components of GLP Standards

GLP encompasses various aspects of the laboratory setting, including but not limited to:

– Organization and Personnel: Ensuring responsibilities are clearly defined and staff appropriately qualified and trained.

– Test Facility: The laboratory environment must be suitable for conducting studies safely and effectively.

– Equipment: All equipment must be regularly inspected, cleaned, maintained, and calibrated to ensure accurate results.

– Test Systems: Proper handling and care of biological or chemical test systems to ensure their integrity.

– Test and Reference Items: Management of chemicals, drugs, or other materials being tested, including their labeling, handling, storage, and distribution.

– Standard Operating Procedures (SOPs): Detailed, written instructions to achieve uniformity in the performance of specific functions.

– Performance of the Study: Conducting studies according to the approved plan or protocol should be documented and reported.

– Quality Assurance: A system to ensure studies comply with GLP standards.

Significance of GLP Standards

The implementation of GLP standards has several significant implications:

– Ensuring Safety: By adhering to GLP, laboratories can produce reliable and high-quality data, contributing to product safety evaluation before reaching consumers.

– Regulatory Compliance: Compliance with GLP is often a legal requirement for the regulatory submission of new chemicals or pharmaceuticals, making it critical for laboratories seeking approval for their products.

– International Recognition: Data generated under GLP conditions are more likely to be accepted by international regulatory authorities, facilitating the global distribution of new products.

GLP vs. Other Quality Systems

While GLP shares some similarities with other quality systems like Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP), it’s essential to note that GLP applies explicitly to non-clinical studies. The focus is on pre-clinical trials in laboratory settings. In contrast, GMP and GCP govern the production and clinical trial phases.

Implementing GLP Standards

Implementing GLP standards requires a holistic approach, starting from the top with a strong management commitment to quality. It involves setting up detailed procedures, training personnel, maintaining equipment and facilities, and establishing a robust quality assurance program. Continuous monitoring and improvement are vital to ensuring that GLP standards are met and upheld over time.

Click here to learn more about Visikol’s GLP Mulitplex Tissue Imaging Services or reach out to a member of our team!

Here at Visikol, we recently announced the launch of our multiplex imaging services in a GLP setting (read more here: Visikol GLP Multiplex Tissue Imaging Services), and you may be wondering what this means. In biotechnology, GLP stands for Good Laboratory Practice. GLP is a quality assurance system that ensures the consistent and reliable generation of data in non-clinical safety studies of chemicals, pharmaceuticals, and other products. It provides guidelines and regulations for conducting laboratory experiments and studies in a manner that ensures the integrity, reliability, and traceability of the generated data.

More on GLP Regulations

The GLP regulations encompass a wide range of aspects related to laboratory operations, such as the qualifications and training of personnel, the maintenance and calibration of equipment, the documentation and reporting of experiments, the handling and storage of test substances, and the overall conduct of the study. Compliance with GLP standards is important for regulatory submissions and the acceptance of data by regulatory authorities.

The GLP guidelines were developed to ensure that non-clinical safety studies, which are performed to assess the potential hazards and risks of substances, are conducted in a consistent and rigorous manner. This helps to protect human health and the environment by ensuring that the data generated from these studies are accurate, reliable, and can be independently verified.

Visikol consistently strives to broaden its applications for our clients, and with the addition of GLP imaging services, we aim to diversify the scope of our work within the industry. If you are interested to learn more about our multiplex tissue imaging, reach out to our team to discuss your next project.

Over the last seven years, Visikol has continually been on the forefront of advanced tissue imaging technologies with its introduction of the Visikol HISTO 3D tissue imaging approach and more recently with its fluorescent multiplex tissue imaging services and its Imaging Mass Cytometry services. We are excited to announce that we are now offering our multiplex tissue imaging services in a GLP setting such that they can be applied to a much wider set of applications for our clients.

What is Multiplex Tissue Imaging?

Multiplex tissue imaging refers to the concept of applying multiplex markers (typically >3) to a single tissue so that many biomarkers can be visualized together. Traditionally, chromogenic IHC is limited to 2-3 markers as overlapping colors prevent effective deconvolution. For many applications, only 2-3 markers is acceptable for addressing a research question but it is highly limited for addressing complex research questions. For example, in the context of immunology and immuno-oncology it is critically important to understand the complex interplay between different types of immune cells and the underlying pathology. This complexity necessitates multiple tissue labels where many markers can be visualized simultaneously.

Other Resources

If you are interested in learning more about multiplex tissue imaging check out the resources below or reach out to our team to discuss your next project:

• Multiplex Tissue Imaging eBook
• When to Use IMC Over Multiplex Fluorescence
• Clinical Implications of Multiplex Imaging